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1. Introduction 
Antibodies hould provide a valuable tool to com- 
pare human collagen from different issues as well as 
collagen obtained from normal or pathologic sources. 
To draw reasonable conclusions from such studies a 
detailed knowledge is required on the sites which react 
with the antibodies. The antigenic properties of soluble 
human collagen have already been the subject of several 
reports [1-3] .  Expect for the investigation of Lindsley 
et al. [3] there was as yet no attempt to characterize 
the immunologic activity at the molecular level. Re- 
cently, distinct groups of antigenic determinants could 
be localized in the polypeptide chains of various col- 
lagens [4-7] .  Such attempts became feasible by studying 
separated polypeptide chains of collagen or even smal- 
ler peptides as obtained after cyanogen bromide cleav- 
age. 
This approach was now applied to collagen from 
human dura mater. The present study demonstrated 
an immune response in rabbits to the al -  as well as 
the o~2-chain with an appreciable heterogeneity of 
the antibody specificities involved. The major anti- 
genic site is localized on the C-terminal cyanogen bro- 
mide peptide, al-CB6. Additional antigenic deter- 
minants were found in N-terminal or middle regions 
of the molecule which, however, are recognized either 
less frequently or only with a low antibody response. 
2. Experimental 
Human dura mater was obtained from donors a few 
days to five years old at autopsy and was immediately 
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extracted at 4 ° with 0.5 M sodium acetate containing 
0.1% EDTA. Subsequently the acid-soluble collagen 
was extracted either by 0.05 M citrate buffer pH 3.7 
or 1% acetic acid and was purified by two precipita- 
tions with KC1 [8]. The a-chains were separated by 
CM-cellulose chromatography [9] and the ct2-chains 
further purified by molecular sieve chromatography 
[10]. Since the yields of acid-soluble collagen from 
human tissues are very low, the cyanogen bromide 
peptides (CB-peptides) were prepared from the in- 
soluble collagen not dissolved by the extractions de- 
scribed above. One gram was suspended in 100 ml 
70% formic acid and incubated together with 1 g 
CNBr for 4 hr at room temperature which resulted 
in a complete dissolution of the collagen. The reagents 
were removed onBio-Gel P-2, equilibrated with 0.1 
M acetic acid and the peptides were isolated by lyo- 
philization. The single peptides used in this study 
were purified by conventional chromatographic tech- 
niques [11,12] and were characterized by their mole- 
cular weight [13], by amino acid analysis and by elec- 
tron microscopy [14]. Their designations followed the 
suggestions of Click and Bornstein [15 ] and a detailed 
report will appear elsewhere. 
Antisera against he acid-soluble collagen were pre- 
pared in rabbits by injecting 1 mg antigen, incorpo- 
rated into complete Freund's adjuvant at multiple 
subcutaneous sites, followed by an intraperitoneal 
injection of 2 mg antigen without adjuvant 14 days 
later. This immunization course was usually repeated 
once or twice. Blood was collected 7 days after the 
last injection. For the serological studies the antisera 
were fractionated into two antibody solutions by im- 
munoadsorption a column prepared from dena- 
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Table 1 
Agglutinating activity for red cells coated with different a-chains of antibodies to human collagen. 
February 1971 
Titer (- log 2) for red cells coated with a 
Antibody fraction Collagen if.l-chain Ot2-chain 
Without affinity 5.9 5.8 1.2 
for rabbit 
collagen (4-8)  (3-8)  (< 1-3) 
With affinity 6.2 6.8 4.5 
for rabbit collagen b (4-9)  (4-10) (1-9)  
a Average results from 21 different antisera, the range is given in the brackets. 
b Tenfold concentrated. 
tured rabbit collagen [16]. The antibodies not bound 
onto the immunoadsorbent (antibodies without affinity 
for rabbit collagen) were concentrated by ammonium 
sulfate precipitation to the applied serum volume. The 
bound antibodies (antibodies with affinity for rabbit 
collagen) were eluted with calf collagen peptides and 
were usually studied after a tenfold concentration with 
respect to the antiserum volume applied. 
The specificity of the antibodies was characterized 
by the passive hemagglutination method as previously 
adapted for collagen [17]. Tanned human red cells 
were coated either with denatured collagen, the single 
a-chains or different CB-peptides and the antibody solu- 
tions were titrated against such cells (agglutination test). 
In another approach (inhibition tests) the single a-chains 
or CB-peptides were added to the antibody solutions 
prior to the coated red cells and the titer reduction 
observed was recorded. 
3. Results and discussion 
3.1. Polypeptide chain specificity of the rabbit 
antibodies 
Rabbit antisera to acid-soluble collagen from human 
dura mater contained antibodies which were specifi- 
cally directed to the polypeptide chains of collagen as 
demonstrated by a comparable r activity against red 
cells coated either with collagen or the al-chain. The 
separation of the antibodies on a rabbit collagen im- 
munoadsorbent i o a major non-bound and a minor 
bound fraction allowed the differentiation of the speci- 
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Fig. 1. Hemagglutination inhibition with a l -  and a2-chains. Antibodies without aff'mity for rabbit collagen titrated vs. red cells 
coated with 0tl-chains (a), and antibodies with affinity for rabbit collagen titrated vs. red cells coated either with ¢Xl-chains (b) 
or a2-chains (c). Average results from 6 antisera in each group. 
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Table 2 
Agglutinating activity of antibodies to human collagen for red cells coated with different CB peptides from the human t~l-chain. 
Antibody Serum 
solution no. 
Reciprocal titer vs. red cells coated with 
Collagen otl-chain OtI-CB3 Otl-CB6 Otl-CB7 Otl-CB8 
Without affinity 300 64 128 4 512 < 2 < 2 
for rabbit 301 128 128 4 512 <2 <2 
collagen 313 128 256 <2 4 <2 <2 
340 128 128 8 128 <2 <2 
With affinity 300 512 1024 16 128 1024 64 
for rabbit 301 128 128 8 64 256 64 
collagen a 313 128 128 128 256 < 2 8 
340 128 128 4 32 128 8 
a Tenfold concentrated. 
ficities concerned (table 1). 
The antibodies which do not show affinity for rabbit 
collagen revealed high agglutination titers for al-chain- 
coated red ceils, but reacted not or only weakly with 
the t~2-chain (table 1). Accordingly, al-chains trongly 
inhibited the agglutination of red cells coated with a 1- 
chains, whereas a2-chains proved to be more than ten- 
fold less active (fig. 1 a). 
The antibodies with affinity for rabbit collagen 
reacted in the agglutination tests with both chains, al- 
though the activity was reduced for the a2-chain 
(table 1). Inhibition studies demonstrated heterogeneity 
of these antibodies (fig. lb, c). The agglutination of the 
al-chain or the a2-chain-coated red cells could be bet- 
ter inhibited by the corresponding than by the hetero- 
logous chain. The major part of the antibodies in a single 
solution seems, therefore, to be adapted to the al-chain 
although some antibodies occurred which have a higher 
affinity for the a2-chain. 
In gel diffusion it was demonstrated that the a l -  
chain is solely responsible for the antigenic activity 
of human collagen in rabbits [3]. The lower sensitivity 
of this serologic method when compared with the pas- 
sive hemagglutination technique may, however, ex- 
plain why no reaction with the a2-chain was observed. 
3.2. Localization of antigenic determinants on 
cyanogen bromide peptides 
Definitive proof for the diversity and heterogeneity 
of the individual immune response was obtained by 
studies with purified CB-peptides from the a 1-chain. 
Some representative agglutination patterns for the 
two antibody fractions are given in table 2. 
From 15 different antibody solutions which ex- 
hibit no affinity for rabbit collagen, 13 showed com- 
parable titers for red cells coated with the al-chains 
or the corresponding C-terminal peptide, a1-CB6 
(cf. serum 300,301,340). This result was consistent 
with the finding, that otl-CB6 could effectively in- 
hibit the agglutination of cells coated either with the 
al-chain or t~I-CB6. Since neither in the agglutina- 
tion nor in the inhibition test a strong reaction was 
found for the other large peptides from the middle 
region of the t~l-chain (al-CB3, ctl-CB7 and al-CB8), 
it seems likely that al-CB6 carries very specifically 
one of the major antigenic determinants of human 
collagen. This is in accordance with results obtained 
for calf skin [5] and rat skin collagen [6]. Likewise, 
the human antigenic determinant is very susceptible 
to the action of pronase and should therefore be 
located very close to the C-terminal end of the about 
200 amino acids long sequence of al-CB6. 
One antibody solution (n o. 313), however, revealed 
strong agglutinating activity for the al-chain but not 
for o~I-CB6. This reaction could be inhibited only by 
the N-terminal peptide, otl-CB1, but not by any other 
CB-peptide. Preliminary studies with this antibody 
solution showed complete cross reaction between 
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the peptides ct 1-CB 1 of human and calf origin [ 18 ], 
which contain 20 and 19 amino acid residues, respect- 
ively, and differ only in one glycyl residue [12, 19]. 
These results indicated a very similar amino acid se- 
quence for both peptides. As yet no evidence was ob- 
tained for an antigenic determinant in the N-terminal 
site of the human a2-chain, which seems immunolog- 
ically important in guinea pig and rat skin collagen 
[4, 18]. 
The antibodies with affinity for rabbit collagen 
must differ in specificity from the other, since they 
react mainly with peptides derived from the triple- 
helical part of the polypeptide chain (al-CB3, ctl-CB7 
and al-CB8), but also with the terminal peptide, a l -  
CB6. Inhibition studies uggested that these reaction 
patterns may be best explained by assuming a hetero- 
geneous antibody population which recognizes several 
different antigenic determinants. There are also con- 
siderable individual variations (cf. serum 300 and 313). 
Both results correspond to recent experience [7] on 
similar antibodies obtained from rabbit antisera to rat 
skin and calf skin collagen. 
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